fda shortage semaglutide injection resolved feb 21 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over fda shortage semaglutide injection products
Description
[DOI] [PubMed] [Google Scholar] 16.Zhao L., Cheng Z., Lu Y., et al
Post-marketing surveillance, case reports, and patient community posts do include dry mouth among reported complaints
[DOI] [PubMed] [Google Scholar] 48.Garvey W.T., Birkenfeld A.L., Dicker D., Mingrone G., Pedersen S.D., Satylganova A., Skovgaard D., Sugimoto D., Jensen C., Mosenzon O
Weight loss quality
Retatrutide is still an investigational peptide that has not yet completed the full FDA review process to establish its long-term safety and effectiveness profile
